HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Paulo E Stanga Selected Research

Light Coagulation

1/2016TRANSCLERAL DRAINAGE OF SUBRETINAL FLUID, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR, AND WIDE-FIELD IMAGING-GUIDED LASER IN COATS EXUDATIVE RETINAL DETACHMENT.
5/2013Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy.
2/2013Pilot randomised clinical trial of Pascal TargETEd Retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study.
3/2012Study of clinical applications and safety for Pascal® laser photocoagulation in retinal vascular disorders.
9/2011Randomized clinical trial to evaluate the effects of Pascal panretinal photocoagulation on macular nerve fiber layer: Manchester Pascal Study report 3.
2/2011Spatial and spectral imaging of retinal laser photocoagulation burns.
11/2010Re: Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser.
6/2010Barely visible 10-millisecond pascal laser photocoagulation for diabetic macular edema: observations of clinical effect and burn localization.
5/2010Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study.
4/2010In vivo laser-tissue interactions and healing responses from 20- vs 100-millisecond pulse Pascal photocoagulation burns.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Paulo E Stanga Research Topics

Disease

9Diabetic Retinopathy (Retinopathy, Diabetic)
01/2014 - 04/2010
5Burns
05/2013 - 04/2010
3Retinal Perforations
03/2012 - 01/2010
2Retinal Detachment (Retinal Detachments)
01/2016 - 06/2010
1Retinal Telangiectasis
01/2016
1Disease Progression
01/2016
1Hemorrhage
01/2015
1Cavernous Hemangioma (Cavernous Angioma)
01/2015
1Retinal Degeneration
04/2012
1Retinal Vein Occlusion
03/2012
1Neovascular Glaucoma
03/2012
1Papilledema
06/2010
1Cicatrix (Scar)
06/2010
1Capillary Hemangioma
06/2010
1Macular Edema
06/2010
1Choroidal Neovascularization
05/2009
1Retinoschisis (Retinoschisis, Juvenile)
04/2007
1Macular Degeneration (Age-Related Maculopathy)
04/2007
1Retinal Diseases
01/2003

Drug/Important Bio-Agent (IBA)

11Retinaldehyde (Retinal)IBA
01/2016 - 04/2007
3Fluorescein (Funduscein)FDA LinkGeneric
01/2015 - 01/2003
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 05/2009
1bevacizumabFDA Link
01/2016
1Endothelial Growth FactorsIBA
05/2009
1verteporfin (Visudyne)FDA Link
05/2009
11-phenyl-3,3-dimethyltriazene (PDT)IBA
05/2009

Therapy/Procedure

11Lasers (Laser)
01/2016 - 04/2010
10Light Coagulation
01/2016 - 04/2010
2Photochemotherapy (Photodynamic Therapy)
06/2010 - 05/2009
1Vitrectomy
01/2016
1Visual Prosthesis
04/2012
1Aftercare (After-Treatment)
06/2010